Protocol for Evaluation Effectiveness Monitoring Neurophysiological Per-operative in Surgery Traumatic Acetabular (PESCIATIQUE)

March 7, 2019 updated by: Groupe Hospitalier Paris Saint Joseph
Pelvic fractures in which integrate the acetabulum fractures represent a risk of traumatic injury to the sciatic nerve trunk by stretching or section (1): Judet and Letournel reported a complication rate of around 6% (1). Fractures of the acetabulum strictly speaking are also providers of neurological complications with rates, significant, have recently been precisely detailed by a cohort study published by Lehmann et al. (2): In a series of 2073 patients, the authors reported an overall complication rate of neurological related to the initial trauma of the order of 4%. In this series, 1395 patients were operated with a rate of iatrogenic neurological complications of 2 to 3%. Regarding the first routes (and therefore the types of fractures), the Kocher-Langenbeck path is the path that leads to the greatest number of neurological complications: 3 to 4% in this series (2). However, this cohort study does not specify what truncal achievement it is. Obviously violations posterior acetabular are preferentially providers of sciatic injury while violations prior acetabular are more providers of obturator or femoral lesions. But this is not always the case. Moreover, this study does not specify the type or severity of neurological involvement.

Study Overview

Status

Terminated

Conditions

Detailed Description

Methodology Design: This is an interventional study in routine care, prospective, single-center.

Main objective / secondary:

Primary objective :

To evaluate the sensitivity of the neurophysiological monitoring combining two specific new procedures to detect intraoperative complications on the sciatic trunk (by measuring potential with somatosensory storied collection of P15 and electromyographic recording with the potential of sciatic nerve in the popliteal fossa).

secondary objectives

Frequency of neurophysiological changes on the interventions of the acetabulum.

An anomaly being retained as:

  • Interval prolongation N8-P15> 10%
  • And / or decrease in the amplitude ratio P15 / N22> 50%
  • And / or elongation of the latency of nerve potential> 10% of the value-operative Opré
  • And / or reducing the amplitude of the nerve potential> 50% Correlation between the impact of changes neurophysiological intraoperative and
  • The occurrence of postoperative neurological deficit:

    • motor deficit
    • and / or sensory deficit
    • territory of the sciatic trunk

Correlation between the incidence of intraoperative neurophysiological modifications and:

  • The type of surgery
  • The type of fracture

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile-de-France
      • Paris, Ile-de-France, France, 75014
        • Groupe Hospitalier Paris Saint Joseph

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients sent to the Hospital Group Service Paris Saint Joseph for surgical treatment of fractures of the acetabulum.
  • Anterior and posterior surgical first Routes
  • Major Patient
  • Age <60 years

Exclusion Criteria:

  • Known diabetes treated
  • Previous history of spine surgery
  • Sick antecedent the peripheral or central nervous system known

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neurophysiological monitoring

The neurophysiology team perform:

  • Implementation of the stimulation electrodes and collection (needle electrodes) SEP and EMG as described above.
  • Acquisition of data by the machine and the software Protektor® (Natus) in the following format:

A PES stimulation every 10 minutes consistently. Meanwhile, important surgical time and known to be at risk for neurological injury will be noted and their exact schedule specified:

  • Establishment of a spacer or forceps in the greater or lesser sciatic notch
  • Traction layout

For the ways of Kocher-Langenbeck, a collection of potential nerve sciatic trunk upstream of the critical region:

  • At the end of the incision
  • On the establishment of a spacer or forceps in the greater or lesser sciatic notch
  • When towing layout
  • At the end of the intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the score of electrophysiological intraoperative event
Time Frame: Day -1 before surgery

The Score will be assessed between 1 to 3 (1= negative. 2= average, 3= good):

  • Potential to be studied subsequent stages, after averaging 500 successive traces to the following story:

    o popliteal Hollow: bipolar collection

  • Cathode medial, (1, 2 or 3 Point)
  • Anode side (1, 2 or 3 Point)
  • Recording the distal truncal response N8. (1, 2 or 3 Point)
  • Recorded values:

    • Latency N8 (1, 2 or 3 Point)
    • Amplitude o Basin bipolar collection,
  • Cathode: iliac crest to the stimulated nerve (1, 2 or 3 Point)
  • Anode: ipsilateral gluteal fold ((1, 2 or 3 Point)
  • Recording the P15 response. (1, 2 or 3 Point)
  • Recorded values:

    • Latency P15 (1, 2 or 3 Point)
    • P15 Amplitude (1, 2 or 3 Point)
    • Interval-P15 N8 (1, 2 or 3 Point) o Spinal cord dorsal low Bipolar collection
  • Cathode level D12 (1, 2 or 3 Point)
  • Umbilicus anode (1, 2 or 3 Point)
  • Saving the N22 potential. (1, 2 or 3 Point)
Day -1 before surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Assessment of change of sensitivity: according to the quotation of the ASIA score
Time Frame: Day 2, Month 3, Month 6 et Month 12
Day 2, Month 3, Month 6 et Month 12
Assessment of change of Pain (VAS) Visual Assessment Scale
Time Frame: Day 2, Month 3, Month 6 et Month 12
Day 2, Month 3, Month 6 et Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guillaume P RIOUALLLON, MD, Groupe Hospitalier Paris Saint Joseph

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2015

Primary Completion (Actual)

March 7, 2019

Study Completion (Actual)

March 7, 2019

Study Registration Dates

First Submitted

August 25, 2016

First Submitted That Met QC Criteria

September 9, 2016

First Posted (Estimate)

September 12, 2016

Study Record Updates

Last Update Posted (Actual)

March 8, 2019

Last Update Submitted That Met QC Criteria

March 7, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PESCIATIQUE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Neurophysiological MONITORING

Subscribe